{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-117786","form_type":"8-K","ticker":"SPRB","cik":"0001683553","company_name":"SPRUCE BIOSCIENCES, INC.","filed_at":"2024-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.219761+00:00","generated_at":"2026-05-30T09:43:23.266618+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Spruce Biosciences receives Nasdaq bid-price extension to April 21, 2025; moves to Capital Market","bullets":["Received Nasdaq extension until April 21, 2025 to meet $1.00 minimum bid price.","Stock transfer from Nasdaq Global Select to Capital Market effective Oct 28, 2024.","Must maintain closing bid >=$1.00 for 10 consecutive business days before deadline.","May consider reverse stock split; failure to comply could lead to delisting.","No immediate impact on listing; company intends to monitor bid price."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-117786","json":"https://secwatch.observer/filing/0000950170-24-117786.json","markdown":"https://secwatch.observer/filing/0000950170-24-117786.md","text":"https://secwatch.observer/filing/0000950170-24-117786.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1683553/000095017024117786/0000950170-24-117786-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1683553/000095017024117786/sprb-20241024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:43:23.266618+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}